{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:16:46Z","timestamp":1794971806883,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","award":["Genetic testing was supported by an unrestricted grant from Alexion Pharmaceuticals Inc, which had no role in the study design or data analysis."],"award-info":[{"award-number":["Genetic testing was supported by an unrestricted grant from Alexion Pharmaceuticals Inc, which had no role in the study design or data analysis."]}],"id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypophosphatasia (HPP) is an inborn error of metabolism characterized by low levels of serum alkaline phosphatase (ALP). Scarce evidence exists about features that should signal the potential association between hypophosphatasaemia and HPP in adults. The aim of this study is to estimate the prevalence of <jats:italic>ALPL<\/jats:italic> variants in subjects with persistent hypophosphatasaemia and determine the associated clinical and laboratory features. For this cross-sectional study, laboratory records of 386,353 subjects were screened by measurement of ALP activity. A total of 85 (0.18%) subjects with persistent hypophosphatasaemia (\u22652 serum alkaline phosphatase\u2013ALP\u2013measurements \u226435\u2009IU\/L and none &gt;\u200945\u2009IU\/L) were included (secondary causes previously discarded). <jats:italic>ALPL<\/jats:italic> genetic testing and a systematized questionnaire to retrieve demographic, clinical and laboratory data were performed. Descriptive analysis and logistic regression models were employed to identify the clinical and laboratory characteristics associated with <jats:italic>ALPL<\/jats:italic> variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty subjects <jats:bold>(<\/jats:bold>47%) had a variant(s) in <jats:italic>ALPL<\/jats:italic>. With regard to clinical characteristics, the presence of an <jats:italic>ALPL<\/jats:italic> variant was significantly associated only with musculoskeletal pain (OR: 7.6; 95% IC: 1.9\u201330.9). Nevertheless, a trend to present more dental abnormalities (OR: 3.6; 95% IC: 0.9\u201313.4) was observed. Metatarsal stress fractures were also more frequent (4 vs 0; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in this group. Regarding laboratory features, median ALP levels were lower in subjects with <jats:italic>ALPL<\/jats:italic> variants (26 vs 29\u2009IU\/L; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005). Interestingly, the threshold of ALP levels &lt;\u200925\u2009IU\/L showed a specificity, positive predictive value and positive likelihood ratio of 97.8, 94.4% and 19.8 to detect a positive <jats:italic>ALPL<\/jats:italic> test, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In subjects with persistent hypophosphatasaemia \u2013secondary causes excluded\u2013 one out of two presented <jats:italic>ALPL<\/jats:italic> variants. Musculoskeletal pain and ALP levels &lt;\u200925\u2009IU\/L are associated with this variant(s). In this scenario, ALP levels &lt;\u200925\u2009IU\/L seem to be very useful to identify individuals with the presence of an <jats:italic>ALPL<\/jats:italic> variant.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-1315-y","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T15:07:01Z","timestamp":1581952021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?"],"prefix":"10.1186","volume":"15","author":[{"given":"C.","family":"Tornero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Navarro-Comp\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Tenorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Garc\u00eda-Carazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Monjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Plasencia-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Iturzaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lapunzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Balsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"1315_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","volume":"1192","author":"MP Whyte","year":"2010","unstructured":"Whyte MP. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci. 2010;1192:190\u2013200.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1315_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Mill\u00e1n","year":"2016","unstructured":"Mill\u00e1n JL, Whyte MP. Alkaline phosphatase and Hypophosphatasia. Calcif Tissue Int. 2016;98(4):398\u2013416.","journal-title":"Calcif Tissue Int"},{"issue":"2016","key":"1315_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP. Hypophosphatasia: an overview for 2017. Bone. 2017;102(2016):15\u201325.","journal-title":"Bone"},{"issue":"3","key":"1315_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of Hypophosphatasia in the European population. Ann Hum Genet. 2011;75(3):439\u201345.","journal-title":"Ann Hum Genet"},{"issue":"1","key":"1315_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","volume":"54","author":"KE Berkseth","year":"2013","unstructured":"Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013;54(1):21\u20137.","journal-title":"Bone."},{"issue":"3","key":"1315_CR6","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00198-015-3346-0","volume":"27","author":"E Maman","year":"2016","unstructured":"Maman E, Borderie D, Roux C, Briot K. Absence of recognition of low alkaline phosphatase level in a tertiary care hospital. Osteoporos Int. 2016;27(3):1251\u20134.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1315_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2110","volume":"29","author":"N Gua\u00f1abens","year":"2014","unstructured":"Gua\u00f1abens N, Mumm S, M\u00f6ller I, Gonz\u00e1lez-Roca E, Peris P, Demertzis JL, et al. Calcific Periarthritis as the only clinical manifestation of Hypophosphatasia in middle-aged sisters. J Bone Miner Res. 2014;29(4):929\u201334.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1315_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12018-013-9140-7","volume":"11","author":"E Mornet","year":"2013","unstructured":"Mornet E. Genetics of Hypophosphatasia. Clin Rev Bone Miner Metab. 2013;11(2):71\u20137.","journal-title":"Clin Rev Bone Miner Metab"},{"key":"1315_CR9","unstructured":"The Tissue Nonspecific Alkaline Phosphatase Gene Mutations Database. http:\/\/www.sesep.uvsq.fr\/03_hypo_mutations.php."},{"issue":"10","key":"1315_CR10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ejhg.2014.10","volume":"22","author":"C Hofmann","year":"2014","unstructured":"Hofmann C, Girschick H, Mornet E, Schneider D, Jakob F, Mentrup B. Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia. Eur J Hum Genet. 2014;22(10):1160\u20134.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"1315_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jbmr.2178","volume":"29","author":"FE McKiernan","year":"2014","unstructured":"McKiernan FE, Berg RL, Fuehrer J. Clinical and radiographic findings in adults with persistent hypophosphatasaemia. J Bone Miner Res. 2014 Jul;29(7):1651\u201360.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1315_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RAL Sutton","year":"2012","unstructured":"Sutton RAL, Mumm S, Coburn SP, Ericson KL, Whyte MP. \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res. 2012;27(5):987\u201394.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"1315_CR13","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/jbmr.2495","volume":"30","author":"T Cundy","year":"2015","unstructured":"Cundy T, Michigami T, Tachikawa K, Dray M, Collins JF, Paschalis EP, et al. Reversible deterioration in Hypophosphatasia caused by renal failure with bisphosphonate treatment. J Bone Miner Res. 2015;30(9):1726\u201337.","journal-title":"J Bone Miner Res"},{"key":"1315_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bonr.2016.08.004","volume":"5","author":"M Mori","year":"2016","unstructured":"Mori M, DeArmey SL, Weber TJ, Kishnani PS. Case series: Odontohypophosphatasia or missed diagnosis of childhood\/adult-onset hypophosphatasia? \u2013 Call for a long-term follow-up of premature loss of primary teeth. Bone Rep. 2016;5:228\u201332.","journal-title":"Bone Rep"},{"issue":"1","key":"1315_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-019-2420-8","volume":"20","author":"W H\u00f6gler","year":"2019","unstructured":"H\u00f6gler W, Langman C, Gomes Da Silva H, Fang S, Linglart A, et al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):1\u20139.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"1315_CR16","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, R\u00fcther W, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653\u201362.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1315_CR17","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.metabol.2016.07.006","volume":"65","author":"TJ Weber","year":"2016","unstructured":"Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS. Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metabolism. 2016;65(10):1522\u201330.","journal-title":"Metabolism"},{"key":"1315_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejim.2015.12.019","volume":"29","author":"L Riancho-Zarrabeitia","year":"2016","unstructured":"Riancho-Zarrabeitia L, Garc\u00eda-Unzueta M, Tenorio JA, G\u00f3mez-Gerique JA, Ruiz P\u00e9rez VL, Heath KE, et al. Clinical, biochemical and geneticspectrum of low alkaline phosphatase levels in adults. Eur J Intern Med. 2016;29:40\u20135.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"1315_CR19","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00198-017-4035-y","volume":"28","author":"FE McKiernan","year":"2017","unstructured":"McKiernan FE, Dong J, Berg RL, Scotty E, Mundt P, Larson L, et al. Mutational and biochemical findings in adults with persistent hypophosphatasaemia. Osteoporos Int. 2017;28(8):2343\u20138.","journal-title":"Osteoporos Int"},{"key":"1315_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"10","key":"1315_CR21","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/jbmr.3226","volume":"32","author":"JR Shapiro","year":"2017","unstructured":"Shapiro JR, Lewiecki EM. Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res. 2017;32(10):1977\u201380.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1315_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP. Hypophosphatasia \u2014 aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233\u201346.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1315_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ymgme.2015.09.010","volume":"116","author":"A Taillandier","year":"2015","unstructured":"Taillandier A, Domingues C, De Cazanove C, Porquet-Bordes V, Monnot S, Kiffer-Moreira T, et al. Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted next generation sequencing. Mol Genet Metab. 2015;116(3):215\u201320.","journal-title":"Mol Genet Metab"},{"issue":"35","key":"1315_CR24","doi-asserted-by":"publisher","first-page":"24168","DOI":"10.1074\/jbc.M114.576843","volume":"289","author":"J Silvent","year":"2014","unstructured":"Silvent J, Gasse B, Mornet E, Sire J-Y. Molecular evolution of the tissue-nonspecific alkaline phosphatase allows prediction and validation of missense mutations responsible for Hypophosphatasia. J Biol Chem. 2014;289(35):24168\u201379.","journal-title":"J Biol Chem"},{"issue":"4","key":"1315_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/sj.ejhg.5200190","volume":"6","author":"E Mornet","year":"1998","unstructured":"Mornet E, Taillandier A, Peyramaure S, Kaper F, Muller F, Brenner R, et al. Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia. Eur J Hum Genet. 1998;6(4):308\u201314.","journal-title":"Eur J Hum Genet"},{"key":"1315_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients. Bone. 2015;75:229\u201339.","journal-title":"Bone"},{"issue":"12","key":"1315_CR27","first-page":"4458","volume":"81","author":"K Ozono","year":"1996","unstructured":"Ozono K, Yamagata M, Michigami T, Nakajima S, Sakai N, Cai G, et al. Identification of novel missense mutations (Phe310Leu and Gly439Arg) in a neonatal case of hypophosphatasia. J Clin Endocrinol Metab. 1996;81(12):4458\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1315_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/mgme.2001.3283","volume":"75","author":"S Mumm","year":"2002","unstructured":"Mumm S, Jones J, Finnegan P, Henthorn PS, Podgornik MN, Whyte MP. Denaturing gradient gel electrophoresis analysis of the tissue nonspecific alkaline phosphatase isoenzyme gene in hypophosphatasia. Mol Genet Metab. 2002;75(2):143\u201353.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1315_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ajmg.a.37991","volume":"173","author":"J Tenorio","year":"2017","unstructured":"Tenorio J, \u00c1lvarez I, Riancho-Zarrabeitia L, Martos-Moreno G, Mandrile G, de la Flor CM, et al. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia. Am J Med Genet Part A. 2017;173(3):601\u201310.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"1315_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/humu.1154","volume":"18","author":"A Taillandier","year":"2001","unstructured":"Taillandier A, Lia-Baldini AS, Mouchard M, Robin B, Muller F, Simon-Bouy B, et al. Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasia. Hum Mutat. 2001;18(1):83\u20134.","journal-title":"Hum Mutat"},{"key":"1315_CR31","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/hmg\/3.9.1683","volume":"3","author":"H Orimo","year":"1994","unstructured":"Orimo H, Hayashi Z, Watanabe A, Hirayama T, Hirayama T. Novel missense and frameshift mutations in the tissue-nonspecific alkaline phosphatase gene in a Japanese patient with hypophosphatasia. Hum Mol Genet. 1994;3:1683\u20134.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1315_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/humu.9159","volume":"22","author":"M Spentchian","year":"2003","unstructured":"Spentchian M, Merrien Y, Herasse M, Dobbie Z, Gl\u00e4ser D, Holder SE, et al. Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat. 2003;22(1):105\u20136.","journal-title":"Hum Mutat"},{"issue":"2","key":"1315_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1006\/geno.1997.4733","volume":"42","author":"H Orimo","year":"1997","unstructured":"Orimo H, Goseki-Sone M, Sato S, Shimada T. Detection of deletion 1154-1156 hypophosphatasia mutation using TNSALP exon amplification. Genomics. 1997;42(2):364\u20136.","journal-title":"Genomics"},{"issue":"3","key":"1315_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<293::AID-HUMU11>3.0.CO;2-Q","volume":"15","author":"A Taillandier","year":"2000","unstructured":"Taillandier A, Cozien E, Muller F, Merrien Y, Bonnin E, Fribourg C, et al. Fifteen new mutations (\u2212195C&gt;T, L-12X, 298-2A&gt;G, T117N, A159T, R229S, 997+2T&gt;A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasia. Hum Mutat. 2000;15(3):293.","journal-title":"Hum Mutat"},{"issue":"20","key":"1315_CR35","doi-asserted-by":"publisher","first-page":"9924","DOI":"10.1073\/pnas.89.20.9924","volume":"89","author":"PS Henthorn","year":"1992","unstructured":"Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci U S A. 1992;89(20):9924\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1315_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/(SICI)1098-1004(1999)13:2<171::AID-HUMU16>3.0.CO;2-T","volume":"13","author":"A Taillandier","year":"1999","unstructured":"Taillandier A, Zurutuza L, Muller F, Simon-Bouy B, Serre JL, Bird L, et al. Characterization of eleven novel mutations (M45L, R119H, 544delG, G145V, H154Y, C184Y, D289V, 862+5A, 1172delC, R411X, E459K) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with severe hypophosphatasia. Hum Mutat. 1999;13(2):171\u20132.","journal-title":"Hum Mutat"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1315-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:50:45Z","timestamp":1613580645000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1315-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1315-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"31 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study adhered to the tenets of the Declaration of Helsinki and approval was obtained from La Paz University Hospital\u2019s ethics committee. Each subject provided written informed consent prior to inclusion.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P. Aguado has received fees for advisory board participation from Alexion (Spain) and is a recipient of an unrestricted research grant from this pharmaceutical company, but not for this manuscript. The rest of authors declare they do not have any other conflict of interest regarding the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}